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        The immune system produces a diverse array of 
antibodies by a series of DNA transactions that 
require programmed DNA damage.   Ig   transcrip-
tion units are assembled by random joining of 
variable (V), diversity (D), and joining (J) gene 
segments by a site-specifi  c recombination reac-
tion mediated by RAG1 and RAG2 proteins in 
developing B cells (  1, 2  ). Later, during immune 
responses, antigen-specifi  c clones of B cells are 
selectively expanded in structures called germi-
nal centers (GCs), where they undergo Ig so-
matic mutation and class switch recombination 
(CSR) (  3, 4  ). Somatic hypermutation (SHM) 
introduces nontemplate nucleotide substitutions 
into the   Ig   variable gene (  5  ), which can alter the 
binding affi   nity of the antibody molecule. If the 
affi   nity is enhanced, the resulting B cell clone is 
selectively expanded, ultimately resulting in af-
fi  nity maturation of the antibody response (  3, 4  ). 
CSR is a region-specifi  c deletional recombi-
nation reaction that replaces one antibody-
constant region for another, thereby altering 
antibody eff  ector function (  6  –  11  ). Class switch-
ing does not involve the variable regions, and 
therefore switched antibodies retain their anti-
genic specifi  city. Although somatic mutation 
and class switching are fundamentally diff  erent 
DNA transactions, they are initiated in the nu-
cleus by the same enzyme, activation-induced 
cytidine deaminase (AID) (  12  –  14  ), which intro-
duces uracil:guanine mismatches in transcribed 
single-stranded (ss)   Ig   DNA (  15  –  19  ). 
  In addition to its eff  ects on   Igs  , AID pro-
duces off  -target DNA damage, including point 
mutations in oncogenes such as   bcl6   or   c-myc 
  (  20  –  23  ), and it also induces double-stranded 
DNA breaks in   Igs   that serve as substrates for 
chromosome translocations (  24  –  26  ). DNA dam-
age by AID is minimized in part because AID 
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However, AID can also produce off-target DNA damage, including mutations in oncogenes. 
Therefore, stringent regulation of AID is required for maintaining genomic stability during 
maturation of the antibody response. It has been proposed that AID phosphorylation at 
serine 38 (S38) regulates its activity, but this has not been tested in vivo. Using a combina-
tion of mass spectrometry and immunochemical approaches, we found that in addition to 
S38, AID is also phosphorylated at position threonine 140 (T140). Mutation of either S38 
or T140 to alanine does not impact catalytic activity, but interferes with class switching 
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not PKA (  Fig. 1 E  ). The PKC family is composed of at least 
10 serine/threonine kinases, and anti-p140 and -p38 was re-
active to varying degrees with recombinant AID after in vitro 
phosphorylation with the diff  erent isoforms (  Fig. 1 F  ). We 
conclude that AID is phosphorylated at position T140 and 
that this site of posttranslational modifi  cation resembles S38 
in that it is not B cell specifi  c. 
  To determine whether T140 is essential for catalytic ac-
tivity, we compared wild-type and AID-T140A for their 
ability to revert an inactivating point mutation in a kanamy-
cin resistance encoding plasmid in   Escherichia coli   (  19  ). Rever-
sion of the point mutation (CCA  P94   to CTA  L94  ) by cytidine 
deamination confers kanamycin resistance, which is assayed 
by colony formation (  19  ). AID-T140A, AID-S38A, and the 
double mutant (AID-ST/AA) were indistinguishable from 
expression is restricted to activated B cells within GCs (  13  ) by a 
requirement for PAX5 and E47 transcription factors (  27, 28  ). 
  AID levels are limiting for CSR and hypermutation (  29  –
  31  ), and they are known to be regulated by microRNA-155, 
which controls the half-life of AID mRNA (  30, 32  ). In addi-
tion, the concentration of AID in the nucleus is limited by a 
combination of active export and selective nuclear degradation 
(  33  –  36  ). Finally, biochemical and tissue culture experiments 
indicate that a fraction of AID is posttranslationally modifi  ed 
by phosphorylation of serine 38 (S38) and that this modifi  ca-
tion may also regulate AID activity (  29, 37, 38  ). 
  S38 is thought to be a target of c-AMP  –  dependent pro-
tein kinase A (PKA) because S38 is part of a PKA consensus 
site and can be phosphorylated in vitro by PKA (  37  ). Further-
more, coimmunoprecipitation experiments showed that AID 
is physically associated with PKA (  37, 38  ). In biochemical as-
says phosphorylation at S38 is essential for AID to associate 
with replication protein A (RPA), a single stranded DNA 
binding protein, and the interaction is required for AID to 
access actively transcribed DNA (  37  ). Consistent with this 
observation, AID phosphorylated at S38 is enriched in chro-
matin (  29  ). 
  Although the role of S38 phosphorylation has not been 
tested in vivo, mutating S38 to alanine (AID  S38A  ) results in 
catalytically intact AID, which may have an altered substrate 
preference in biochemical assays in vitro (  29, 37, 39  ). Expres-
sion of AID  S38A   has also been reported to variably decrease 
CSR assayed in AID-defi  cient B cells in vitro (10  –  80% of 
wild type) (  29, 37, 38, 40  ) and SHM and gene conversion in 
chicken DT40 B cells (15% of wild type) (  41  ). Further con-
founding the question of the function of S38 phosphoryla-
tion is the fact that zebrafi  sh AID lacks a serine at this position, 
yet retains activity in CSR and gene conversion (  41  –  43  ). 
  In this study, we report on a novel site of AID phosphor-
ylation at threonine 140 (T140) and examine the impact of 
S38 and T140 phosphorylation on CSR and SHM in vivo. 
    RESULTS   
  To examine posttranslational modifi  cation of AID, we puri-
fi  ed the protein from B cells cultured with LPS and IL-4 and 
subjected the material to mass spectrometry. Analysis of puri-
fi  ed AID confi  rmed phosphorylation at peptides containing 
S38 (p38), and tyrosine 184 (p184) (  29, 37  ) and revealed ad-
ditional phosphorylation at T140 (p140;   Fig. 1 A  ).   
  To confi  rm that AID is phosphorylated at T140 in vivo, 
we produced AID-p140 phosphospecifi   c antibodies (anti-
p140). Anti-p140 was reactive with AID purifi  ed from B 
cells stimulated with LPS and IL-4, but was not reactive with 
AID-T140A (  Fig. 1 B  ). The level of anti-p140 reactivity in 
cultured B cells diff  ered depending on the stimulus with the 
highest levels found with CpG ( Fig. 1 C ). However, phosphoryl-
ation at AID-T140 was not B cell specifi  c and could also be 
detected in NIH-3T3 NTZ cells expressing AID (  Fig. 1 D  ). 
Finally, anti-p140 did not react with recombinant AID pro-
duced in bacteria, but was reactive with AID phosphorylated 
in vitro with protein kinase C (PKC) catalytic subunit and 
    Figure 1.         AID is phosphorylated at position T140.   (A) Amino acid 
sequence of AID showing the location of S38 and T140 within consensus 
PKA and PKC sites, respectively (gray boxes). (B) Anti-p140 or -AID immuno-
blot of recombinant AID (rAID) purifi  ed from   E. coli   or FLAG-tagged AID 
or AID-T140A immunoprecipitated from retroviral infected AID      /      B  cells 
(* denotes 27-kD FLAG-tagged AID). (C) Anti-p140 and -AID immunoblot 
of FLAG-tagged AID purifi  ed from B cells stimulated with LPS, LPS and IL-4, 
CpG, or anti-CD40 and IL-4. (D) Anti-p140 and -AID immunoblot of 
FLAG-tagged AID purifi  ed from B cells or NTZ-3T3 cells. (E) Anti-p140 and 
-AID immunoblot of rAID untreated (-) or treated with PKC or PKA 
in vitro. (F) Anti-p140, -p38, and -AID immunoblot of rAID untreated (-) 
or in vitro phosphorylated with the indicated PKC isoforms.     JEM VOL. 205, October 27, 2008 
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displayed a   >  40% increase in isotype switching (  Fig. 2 J  ). We 
conclude that AID levels are rate limiting and that superphysi-
ological levels can drive higher rates of isotype switching. 
  To examine the physiological function of AID phosphoryl-
ation at positions S38 and T140, we produced mice that carry 
S38A or T140A mutations in   AID  , AID  S38A  , and AID  T140A  , 
respectively (Fig. S1, available at http://www.jem.org/cgi/
content/full/jem.20081319/DC1). AID  S38A   and AID  T140A   
mutant B cells developed normally (not depicted) and were as-
sayed for CSR to IgG1 after stimulation with LPS and IL-4 
in culture. Cell division was monitored by labeling cells with 
CFSE and tracking dye dilution by fl  ow cytometry. AID pro-
tein levels expressed by wild-type, AID  S38A  , and AID  T140A   B 
cells were indistinguishable when measured by Western blot-
ting (  Fig. 3 A  ), and heterozygous AID  +/      , AID  S38A/      , and 
AID  T140A/       expressed half as much AID as their homozygous 
counterparts (  Fig. 3 A  ).   AID  S38A   and AID  T140A   B cells divided 
normally in response to LPS and IL-4, but were impaired in 
switch recombination to IgG1 (  Fig. 3, B and C  ). AID  S38A   mu-
tant B cells showed 32% the level of CSR to IgG1 of wild-type 
controls, whereas AID  T140   produced a milder defect resulting 
in 87% of wild-type CSR (  Fig. 3, B and C  ). In both cases, the 
defect was exacerbated in haploinsuffi   cient mice. Although 
AID  +/       B cells displayed IgG1 switching, 80% of wild-type B 
cells, AID  S38A/      , and AID  T140A/       showed 4 and 45% the level 
of wild-type B cells, respectively (  Fig. 3, B and C  ). This rela-
tive decrease was consistent within each experiment, despite 
overall switching rates varying from experiment to experiment 
(  Fig. 3, B and C  ). We also measured mutation within the re-
gion 5      of the S      switch repeats. Similar to CSR, AID  S38A   and 
AID  T140A   had mutation rates of 25 and 85%, respectively, com-
pared with WT (  Fig. 3 D  ). Because diff  erent stimulation con-
ditions may result in diff  erential levels of AID phosphorylation 
(  Fig. 1 C  ), we measured isotype switching to IgG3. After stim-
ulation with LPS or LPS and anti-dextran in culture, AID  S38A   
B cells showed 19 or 16% the level of CSR to IgG3 of wild-
type controls, whereas AID  T140A   produced a milder defect 
resulting in 71 or 52% wild-type CSR (  Fig. 3, E and F  ). We 
conclude that both AID-S38 and -T140 phosphorylation are 
required for physiological levels of CSR, but neither is essen-
tial for this reaction. 
  To examine the role of AID phosphorylation in SHM, we 
cloned and sequenced the DNA region downstream of IgJ  H  4 
from purifi  ed lymph node GC B cells (  46  ). The eff  ect of 
AID  S38A   on somatic mutation was similar to CSR, resulting in 
30% of wild-type activity (  Fig. 4 A  ).   In contrast, AID  T140A   had 
more profound eff  ects on somatic mutation than CSR, result-
ing in 45% of wild-type activity, which was not signifi  cantly 
diff  erent from AID  S38A   (  Fig. 4 A  ). Similar results were obtained 
from Peyer  ’  s patch B cells, where mutation rates for AID  S38A   
and AID  T140A   were 20 and 40% of controls, respectively ( Fig. 4 B ). 
Haploinsuffi   ciency by itself resulted in a mild decrease in hyper-
mutation with 70% hypermutation activity in AID  +/       versus 
wild type (  Fig. 4 A  ). Haploinsuffi   ciency magnifi  ed the defect 
in hypermutation of AID  S38A/       and AID  T140A/      , with neither 
statistically rising above the background levels of mutation 
wild type in this assay (  Fig. 2 A  ) (  29  ).   Thus, these mutations 
do not alter AID catalytic activity as assayed in   E. coli  . 
  To determine whether there is interdependence be-
tween S38 and T140 phosphorylation, we expressed AID, 
AID-S38A, or AID-T140A in stimulated AID       /       B cells and 
performed Western blotting experiments with anti-p140 and -
p38 antibodies. We found that AID-S38A was normally phos-
phorylated at position T140 and, conversely, that AID-T140A 
was normally phosphorylated at S38. We conclude that the 
two sites of phosphorylation are not interdependent (  Fig. 2 B  ). 
  AID is phosphorylated in 3T3 fi  broblasts (  Fig. 1 D  ) and 
mutates indicator substrates when it is expressed in these cells. 
Mutator activity can be measured by reversion of a green fl  u-
orescent protein indicator containing a premature stop codon 
(NIH-3T3 NTZ cells [  44  ]). When assayed by FACS or se-
quencing, AID-S38A and -T140A showed   <  15 and   <  50% of 
wild-type levels, respectively (  Fig. 2, C and D  ) (  29  ). We con-
clude that T140 is required for normal levels of mutation in 
NIH-3T3 NTZ cells in vitro. 
  AID can be assayed for its ability to induce CSR in B cells 
in vitro by retroviral complementation of AID-defi  cient B 
cells stimulated with LPS and IL-4 (  45  ). Because AID ex-
pression levels may impact on the results of the assay, we used 
two retroviral vectors that directed diff  erent levels of AID ex-
pression (  Fig. 2 E  ). B cell retroviral infection with PMX-AID 
(  25  ) or MK-AID, which contains a mutant Kozak sequence, 
results in AID levels that are 10- or 2.5-fold higher than 
physiological levels, respectively (  Fig. 2 E  ). Consistent with 
the high levels of AID expression, B cells infected with PMX-
AID switched to IgG1 at higher effi   ciency than cells infected 
with MK-AID (  Fig. 2, F and H  ). AID mutants showed vary-
ing degrees of activity in this assay (  Fig. 2, F and H  ). High 
levels of AID-T140A expression reconstituted nearly 95% of 
control levels of class switching (  Fig. 2, F and G  ). In contrast, 
lower levels of AID-T140A expression resulted in 50% of 
control levels of switching (  Fig. 2, H and I  ). As previously re-
ported, AID-S38A mutants varied in activity depending on 
expression levels ranging from nearly undetectable to 60% of 
control levels (  Fig. 2, G and I  ) (  29, 37, 38, 40  ). High-level 
expression of the double mutant, AID-ST/AA, resulted in a 
modest drop in class switching compared with AID-S38A, 35 
versus 55% of control levels of switching, respectively, which 
is consistent with an additive eff  ect of the two mutations (  Fig. 2, 
F and G  ). We conclude that phosphorylation of S38 and 
T140 are important for class switching in LPS- and IL-4  –
  stimulated B cells. Furthermore, higher levels of AID ex-
pression drive higher levels of switching to IgG1 and diminish 
the requirement for S38 or T140 phosphorylation. Therefore, 
the precise contribution of these posttranslational modifi  ca-
tions to AID function is diffi   cult to evaluate in this assay. 
  To determine if AID protein levels are a rate-limiting factor 
in CSR, we augmented AID levels in wild-type LPS- and IL-4  –
  stimulated B cells with retrovirally expressed AID and mea-
sured isotype switching to IgG1. Compared with wild type 
alone or wild type transduced with empty PMX retrovirus, 
cells supplemented with AID from the PMX-AID retrovirus 2588  PHOSPHORYLATION REGULATES AID ACTIVITY   | McBride et al. 
    Figure 2.         Comparison of AID, AID  T140A  , and AID  S38A   hypermutation and CSR activity in B and non  –  B cells.   (A) The graph shows a log plot of 
numbers of kanamycin-resistant (Kan  R  ) colonies after induction of AID, AID  S38A ,  AID T140A ,  AID ST-AA  , or empty vector expression. (B) Anti-p140, -p38, or -AID 
immunoblot of FLAG-tagged AID, AID  S38A  , or AID  T140A   purifi  ed from B cells stimulated with LPS and IL-4. (C) Accumulation of GFP-expressing 3T3-NTZ cells 
after transduction with AID-, AID  S38A  -, or AID  T140A  -expressing PMX-MK retroviruses. The x axis indicates the number of days after transduction, and the 
y axis indicates the percentage of GFP-positive cells measured by fl  ow cytometry. (D) Number of mutations in the GFP gene cloned from 3T3-NTZ cells 11 d 
after transduction with retroviruses encoding AID, AID  S38A ,  AID T140A  , or control. Segment sizes in the pie charts are proportional to the number of se-
quences carrying the number of mutations indicated in the periphery of the charts. The total number of independent sequences analyzed is indicated in 
the center of each chart. Statistical signifi  cance was determined by a two-tailed Student  ’  s   t   test assuming unequal variance and comparing AID express-
ing with AID  S38A  - and AID  T140A  -expressing cells. P values are indicated. The numbers of point mutations were as follows: 4 mutations/21,643 bp mutations 
for vector; 59 mutations/13,174 bp for AID; 15 mutations/19,761 bp for AID  S38A  ; and 45 mutations/21,643 bp for AID  T140A  . (E) Schematic of retroviral con-
structs used (top); anti-AID immunoblot of AID      /      B cells infected with PMX-AID, or -AID  S38A  , or -AID  T140A  , or   –  AID  ST-AA   (middle); or wild-type B cells (WT) 
or AID      /      B cells infected with PMX-AID, MK-AID, or -AID  S38A  , or -AID  T140A ,  or   – AID ST-AA   (bottom). Anti-tubulin was used as a loading control. (F) Graph of 
fl  ow cytometric analysis of IgG1 expression in AID      /      B cells transduced with PMX-AID, -AID  S38A ,  -AID T140A ,  -AID ST-AA  , or control vector and cultured in LPS 
plus IL-4 for 3 d after infection. The percentage of IgG1  +   cells is indicated for fi  ve independent experiments, and the mean is indicated by a solid line. JEM VOL. 205, October 27, 2008 
ARTICLE
2589 
S38A is active at between 20 and 35% of wild-type levels in 
hypermutation and CSR in vivo. One way to reconcile these 
results would be to posit that association between AID and 
RPA is only required for a subset of AID substrates that do not 
stabilize ss regions spontaneously. For example, ssDNA in 
switch regions is stabilized spontaneously by R-loops, but this 
does not occur in Ig variable region DNA. This model might 
predict that the S38A mutation would preferentially interfere 
with Ig variable region hypermutation (  49, 50  ). However, the 
AID  S38A   mutation aff   ects switching and mutation equally; 
therefore, the mechanism by which S38 phosphorylation al-
ters AID function is likely to be independent of whether the 
ssDNA substrate is created by R-loops. An alternative nonex-
clusive explanation for our results is that S38 phosphorylation 
enhances AID activity by facilitating its interaction with chro-
matin (  29  ). 
  Biochemical studies with AID purifi  ed from insect cells 
assayed on artifi  cial substrates showed that S38A mutation 
does not alter overall AID activity, but shifts target preference 
in a way that might result in specifi  c loss of activity on hot-
spots found in the   Ig   switch region (  39  ). This in vitro bias is 
not consistent with our mutation data in transfected fi  bro-
blasts or GC B cells because we fi  nd lower levels of SHM in 
all cases and the selective hotspot bias found in the in vitro 
transcription systems would not aff  ect the rate of SHM (  29  ). 
  Previous coimmunoprecipitation and in vitro kinase ex-
periments suggest that PKA phosphorylates AID at S38; the 
importance of this kinase in regulating AID is supported by 
the fi  nding that inhibition of its activity in B cells inhibits class 
switching (  37, 38  ). Our experiments indicate that T140 is not 
a PKA target site, and that S38 can be phosphorylated by ei-
ther PKA or PKC in vitro (  Fig. 1 E  ). In addition, PKC family 
members overlap in their preference to phosphorylate T140 
or S38 in vitro (  Fig. 1 F  ) and S38 or T140 phosphorylation is 
nonexclusive (  Fig. 2 B  ). Thus, AID activity may be modu-
lated by phosphorylation on one or both sites, depending on 
which kinase is activated. The PKC family is composed of 
at least 10 serine/threonine kinases, many of which are ex-
pressed in activated B cells (  51, 52  ). They have been impli-
cated in a wide variety of cellular processes, including growth, 
diff  erentiation, tolerance, immunity, and tumor development 
(  51  ). Which family members phosphorylate AID and the pre-
cise pathways that regulate phosphorylation in vivo remains 
to be determined. 
  How T140 phosphorylation modulates AID activity is not 
known, but this modifi  cation diff  ers from S38 in that it 
preferentially aff  ects somatic mutation. Diff  erential regulation 
found in AID       /       lymph node GC B cells (  Fig. 4 A  ). Similar, 
but slightly less pronounced, eff  ects were found in chronically 
stimulated Peyer  ’  s patch GC B cells (  Fig. 4 B  ). We conclude 
that both AID-S38 and -T140 phosphorylation are required for 
optimal somatic mutation and that the T140 has a more pro-
found eff  ect on this reaction than on CSR (  Fig. 4 C  ). 
  AID-defi  cient mice and humans have large GCs com-
pared with controls (  12, 14  ). To determine whether this 
eff  ect is caused by loss of AID protein or its activity, we 
measured the number of GC B cells in AID       /      , AID  +/      , 
AID  T140A/-  , AID  S38A/      , and wild-type mice (  Fig. 5, A and B  ).   
We found that the amount of AID activity was inversely pro-
portional to the size of the GC response. AID       /       mice showed 
the highest number of GC B cells, wild-type mice the fewest, 
and AID  +/       haploinsuffi     cient mice were intermediate be-
tween the two (  Fig. 5, A and B  ). Decreasing AID activity, 
but not protein, in AID  S38A/       mice resulted in an increase in 
the number of GC B cells proportional with the relative de-
crease in activity when compared with AID  +/       controls (  Fig. 
5, A and B  ). We conclude that the number of GC B cells in 
immunized mice is inversely proportional to the amount of 
AID activity. 
    DISCUSSION   
  Mice and humans defi  cient in AID have larger GCs than 
controls (  12, 14  ). In this study, we observe larger GCs in 
AID-haploinsuffi     cient mice together with further enlarge-
ment in AID  S38A/       mice, indicating that the GC phenotype is 
directly related to the level of AID activity. AID activity 
might impact GC size by a variety of mechanisms, including 
antibody gene or generalized genomic damage. For example, 
increased AID activity could result in higher rates of detri-
mental antibody gene mutation, leading to loss of affi   nity, 
loss of expression, or development of self-reactive antibodies 
(  3, 4  ). Conversely, higher rates of off  -target genomic damage 
by AID may lead to mutations that result in cell death (  47  ). 
Irrespective of the mechanism, the magnitude of the eff  ect of 
AID levels on GC size emphasizes the importance of AID 
regulation in vivo. 
  Phosphorylation of AID at position S38 is believed to fa-
cilitate the interaction between AID and RPA, a cofactor that 
is required for AID to access transcribed DNA in vitro (  37  ). 
RPA binds to ssDNA and it was proposed that RPA might 
stabilize ssDNA liberated during transcription to serve as a 
substrate for AID (  48  ). Consistent with this idea, AID-S38A is 
inactive on transcribed dsDNA in the absence of RPA, while 
retaining catalytic activity on ssDNA (  37  ). Nevertheless, AID-
(G) Relative effi  ciency of isotype switching to IgG1. A comparison of PMX-AID versus AID  S38A ,  AID T140A ,  AID ST-AA  , or vector control. Bars represent the mean 
and SD from the fi  ve independent experiments in F. (H) Graph of fl  ow cytometric analysis of IgG1 expression in AID      /      B cells transduced with PMX-AID, 
MK-AID, -AID  S38A ,  -AID T140A ,  -AID ST-AA  , or control vector and cultured in LPS plus IL-4 for 3 d after infection. The percentage of IgG1  +   cells is indicated for 
three independent experiments, and the mean is indicated by a solid line. (I) Relative effi  ciency of isotype switching to IgG1. Bars represent the mean and 
SD from H. (J) Flow cytometric analysis of IgG1 expression in wild-type B cells alone or transduced with MK-AID, PMX-AID, or control vector and cultured 
in LPS plus IL-4 for 3 d after infection. The percentage of GFP         or  GFP +   that were IgG1  +   is indicated on the top left or right of each graph, respectively. 
Graphs are representative of three independent experiments.     
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    Figure 3.         CSR in AID  S38A   and AID  T140A   mice.   (A) Anti-AID immunoblot of AID      /    ,  AID +/     ,  AID T140A/     ,  AID S38A/      , wild-type (WT), AID  T140A  , and AID  S38A   B 
cells stimulated with LPS and IL-4. Anti-tubulin immunoblot was used as a loading control. (B) Flow cytometric analysis of IgG1 expression and CFSE dye 
dilution by WT, AID      /    ,  AID T140A  , and AID  S38A   (top) or AID  +/     ,  AID     /    ,  AID T140A/      , or AID  S38A/       B cells (bottom) stimulated with LPS and IL-4. The percentage of 
IgG1  +   cells is indicated on the top right of each graph. (C) Isotype switching to IgG1 by WT, AID  T140A  , and AID  S38A   (top) or AID  T140A/     ,  AID S38A/      , and AID  +/      
cells (bottom) as in B for the indicated number of independent experiments. Solid lines represent means. Bar graphs represent the mean relative effi  ciency 
and SD of IgG1 CSR compared with WT. (D) Number of mutations in the 5      of  S     region cloned from AID      /     , WT, AID  T140A  , and AID  S38A   B cells stimulated 
with LPS and IL-4 sorted for IgM expression and fi  ve cell divisions. Pie charts and statistical analysis, as in   Fig. 2 D  , represent summary of two experi-
ments. The numbers of point mutations were as follows: 3 mutations/59,185 bp mutations for AID      /     ; 18 mutations/77,875 bp for WT; 11 muta-
tions/115,255 bp for AID  S38A  ; and 24 mutations/117,747 bp for AID  T140A  . (E) Flow cytometric analysis of IgG3 expression in AID      /     , WT, AID  T140A  , and AID  S38A  
B cells stimulated with LPS or LPS and anti-dextran for 6 d. The percentage of IgG3  +   cell is indicated on the top left of each graph. (F) Results of E from 
three independent experiments. Solid line represents the mean.     JEM VOL. 205, October 27, 2008 
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of class switching and somatic mutation is a well-characterized 
physiological feature of gene diversifi  cation in B cells. For ex-
ample, B cells undergoing switch recombination in response to 
LPS and IL-4 in vitro do not mutate their   Ig   variable regions. 
This cannot be ascribed to a general absence of the factors that 
mediate hypermutation because the DNA 3      of the I      pro-
moter and the switch regions themselves are mutated by AID 
in LPS- and IL-4  –  stimulated B cells. Indeed, the amount of 
mutation in switch regions in AID-T140A  –  expressing B cells 
is directly proportional to the amount of class switching and 
diff  ers from   Ig   variable region gene mutation, which is more 
severely aff  ected (  Fig. 4 C  ). One explanation for the disparity 
between the eff  ects of AID-T140A on switching and mutation 
would be that there are specifi  c requirements for AID in the 
two reactions. This idea is supported by the fi  nding that muta-
tions in the amino or carboxyl terminal regions of AID prefer-
entially aff  ect somatic mutation or class switching (  45, 53  ). 
Finding that phosphorylation at T140 preferentially aff  ects 
somatic mutation suggests a mechanism by which AID activity 
on closely related substrates might be diff  erentially regulated. 
    Figure 4.         SHM in GC B cells from AID  S38A   and AID  T140A   mice.   (A)  GC 
B cells were purifi  ed from the lymph nodes of 5 immunized AID      /    , 
AID  +/     ,  AID T140A/     ,  AID S38A/      , WT, AID  T140A  , or AID  S38A   mice. Pie charts indi-
cated the number of mutations in the intronic region 3      of  J H  4. Pie charts 
and statistical analysis as in 2D. The numbers of point mutations were as 
follows: 2 mutations/33,666 bp mutations for AID      /     ; 184 mutations/
115,116 bp for WT; 41 mutations/96,654 bp for AID  S38A  ; and 65 mutations/
85,794 bp for AID  T140A   (top). 2 mutations/43,440 bp mutations for AID      /    ; 
51 mutations/46,689 bp for AID  +/      ; 5 mutations/66,246 bp for AID  S38A/     ; 
and 8 mutations/71,676 bp for AID  T140A/       (bottom). (B) GC B cells purifi  ed 
from Peyer  ’  s patch analyzed the same as A. The numbers of point muta-
tions were as follows: 2 mutations/43,983 bp mutations for AID      /    ;  227 
mutations/45,612 bp for WT; 33 mutations/35,295 bp for AID  S38A  ; and 95 
mutations/46,698 bp for AID  T140A   (top). 1 mutation/179,191 bp mutations 
for AID      /     ; 34 mutations/20,091 bp for AID  +/      ; 4 mutations/31,494 bp 
for AID  S38A/      ; and 12 mutations/17,919 bp for AID  T140A/       (bottom). 
(C) Summary of effi  ciency of both SHM and isotype switching to IgG1 
relative to wild-type by AID  T140A/     ,  AID S38A/     ,  AID T140A ,and  AID S38A /AID +/      
cells. Bars represent the means from and statistics are reported in   Figs. 3 C, 
3 D, and 4 [A and B]  .     
 
    Figure 5.         Percentage of GC B cells from AID  S38A   and AID  T140A   mice.  
(A) Representative FACS analysis that shows percentage of FAS  + GL7 +   GC 
B cells in AID      /    ,  AID +/     ,  AID T140A/     ,  AID S38A/      , and wild-type (WT) mice 
10 d after immunization. (B) Percentage of GC B cells in the lymph nodes of 
AID      /    ,  AID +/     ,  AID T140A/     ,  AID S38A/      , and WT mice 10 d after immunization 
from 6  –  8 mice. Each point represents an immunization experiment from a 
single mouse.     2592  PHOSPHORYLATION REGULATES AID ACTIVITY   | McBride et al. 
55  °  C (30 s), and at 72  °  C (90 s), and then (5     -GGTCAAGGAACCT-
CAGTCA-3     ) and (5     -TCTCTAGACAGCAACTAC-3     ) for 21 cycles at 
94  °  C (30 s), at 55  °  C (30 s), and at 72  °  C (30 s). For 5           switch region analysis 
after 96-h LPS/IL-4 stimulation, IgM  +   cells from two mice that CFSE label-
ing indicated had divided 5 times were sorted. Conditions and primers were 
previously described (  29  ). The NTZ-3T3 assay and GFP gene mutational 
analysis were performed as previously described 11 d after retrovirus infec-
tion (  33, 44  ). PCR products were cloned into TOPO-TA cloning kit (Invi-
trogen) and sequenced with T7 primer.   E. coli   assays were performed exactly 
as previously described (  19  ). 
  Protein analysis.     Anti-AID and -p38 antibodies were previously described 
(  29  ). To produce anti-p140 antibodies, rabbits were immunized with phos-
phopeptide GVQIGIM(pT)FKDYFYC (AID 133  –  148) coupled to keyhole 
limpet hemocyanin. Phosphospecifi  c antibodies were purifi  ed by negative 
selection on unphosphorylated peptide AID 133  –  148 coupled to Sulfolink 
gel (Thermo Fisher Scientifi  c), followed by positive selection on the phos-
phopeptide. Cells were extracted in lysis buff  er (20 mM Tris, pH 8.0, 400 mM 
NaCl, 1% Nonidet P-40, 0.5 mM EDTA, 25 mM NaF, and 1 mM DTT). 
For immunoprecipitation, 2 mg of extracts were incubated with anti-AID 
antibody and protein A  –  Sepharose (GE Healthcare) for 2 h. For FLAG im-
munoprecipitation, anti-FLAG agarose beads (Sigma-Aldrich) were incu-
bated with extracts for 2 h and AID was eluted with 0.5   μ  g/ml of FLAG 
peptide (Sigma-Aldrich) in lysis buff  er. Western blots were performed on 
immunoprecipitated protein or on 50   μ  g of total cell extracts with the indi-
cated anti-AID antibody; anti-tubulin (Abcam) was used as a loading con-
trol. To compare AID levels from retroviral-infected B cells, Western blots 
were performed on cells sorted for GFP expression. AID purifi  cation and 
mass spectrometry analysis of phosphorylation was performed as previously 
described on extracts from 10  9   wild-type B cells purifi  ed from mouse spleens 
by depletion with anti-CD43 beads (Miltenyi Biotec) and cultured in RPMI 
medium, 10% FBS, 5 ng/ml IL-4 (Sigma-Aldrich), and 25   μ  g/ml LPS 
(Sigma-Aldrich) for 72 h (  29  ). 
  In vitro phosphorylation.     100 ng of purifi  ed recombinant AID protein 
was incubated with PKA as previously described (  29  ) or 0.1 U of PKC cata-
lytic subunit or isoforms (Calbiochem) for 30 min at 30  °  C in a buff  er con-
taining 40 mM MES, pH 6.0, 1 mM EGTA, 10 mM MgCl  2  , 1 mM DTT, 
and 0.1 mM ATP. 
  Online supplemental material.     Fig. S1 shows gene-targeting strategy to 
produce AID  S38A   and AID  T140A   mice. The online supplemental material is 
available at http://www.jem.org/cgi/content/full/jem.20081319/DC1. 
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